Surgical Science Sweden AB (publ) (STO:SUS)

Sweden flag Sweden · Delayed Price · Currency is SEK
147.60
-3.10 (-2.06%)
Jul 18, 2025, 5:29 PM CET
15.04%
Market Cap7.69B
Revenue (ttm)946.54M
Net Income (ttm)141.09M
Shares Out51.03M
EPS (ttm)2.76
PE Ratio54.60
Forward PE32.03
Dividendn/a
Ex-Dividend Daten/a
Volume24,173
Average Volume69,061
Open150.60
Previous Close150.70
Day's Range146.20 - 155.50
52-Week Range106.40 - 192.40
Beta0.63
RSI48.13
Earnings DateAug 21, 2025

About STO:SUS

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy tra... [Read more]

Sector Healthcare
Founded 1997
Employees 274
Stock Exchange Nasdaq Stockholm
Ticker Symbol SUS
Full Company Profile

Financial Performance

In 2024, STO:SUS's revenue was 884.09 million, an increase of 0.14% compared to the previous year's 882.85 million. Earnings were 131.65 million, a decrease of -43.73%.

Financial Statements

News

There is no news available yet.